These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfil guideline recommended targets? A report from the EUROASPIRE III cross-sectional study. Gyberg V; Kotseva K; Dallongeville J; Backer GD; Mellbin L; Rydén L; Wood D; Bacquer DD; Eur J Prev Cardiol; 2015 Jun; 22(6):753-61. PubMed ID: 24691153 [TBL] [Abstract][Full Text] [Related]
3. Strategies to reduce complications of type 2 diabetes. Ullom-Minnich P J Fam Pract; 2004 May; 53(5):366-75. PubMed ID: 15125821 [No Abstract] [Full Text] [Related]
4. Effect of six years intensified multifactorial treatment on levels of hs-CRP and adiponectin in patients with screen detected type 2 diabetes: the ADDITION-Netherlands randomized trial. den Ouden H; Berends J; Stellato RK; Beulens JW; Rutten GE Diabetes Metab Res Rev; 2015 Oct; 31(7):758-66. PubMed ID: 26109470 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the Siksika chronic disease nephropathy-prevention clinic. Ward DR; Novak E; Scott-Douglas N; Brar S; White M; Hemmelgarn BR Can Fam Physician; 2013 Jan; 59(1):e19-25. PubMed ID: 23341675 [TBL] [Abstract][Full Text] [Related]
6. Effect of Optimal Medical Therapy Before Procedures on Outcomes in Coronary Patients Treated With Drug-Eluting Stents. Iijima R; Nakamura M; Matsuyama Y; Muramatsu T; Yokoi H; Hara H; Okada H; Ochiai M; Suwa S; Hozawa H; Kawai K; Awata M; Mukawa H; Fujita H; Nanto S; Am J Cardiol; 2016 Sep; 118(6):790-796. PubMed ID: 27544742 [TBL] [Abstract][Full Text] [Related]
7. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study. Fadini GP; Frison V; Simioni N; Lapolla A; Gatti A; Bossi AC; Del Buono A; Fornengo P; Gottardo L; Laudato M; Perseghin G; Bonora E; Avogaro A J Am Heart Assoc; 2019 Jul; 8(14):e012244. PubMed ID: 31269877 [TBL] [Abstract][Full Text] [Related]
8. Quality of medical management in coronary artery disease. Al Shammeri O; Stafford RS; Alzenaidi A; Al-Hutaly B; Abdulmonem A Ann Saudi Med; 2014; 34(6):488-93. PubMed ID: 25971821 [TBL] [Abstract][Full Text] [Related]
9. Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology. Gyberg V; De Bacquer D; De Backer G; Jennings C; Kotseva K; Mellbin L; Schnell O; Tuomilehto J; Wood D; Rydén L; Amouyel P; Bruthans J; Conde AC; Cifkova R; Deckers JW; De Sutter J; Dilic M; Dolzhenko M; Erglis A; Fras Z; Gaita D; Gotcheva N; Goudevenos J; Heuschmann P; Laucevicius A; Lehto S; Lovic D; Miličić D; Moore D; Nicolaides E; Oganov R; Pająk A; Pogosova N; Reiner Z; Stagmo M; Störk S; Tokgözoğlu L; Vulic D; Cardiovasc Diabetol; 2015 Oct; 14():133. PubMed ID: 26427624 [TBL] [Abstract][Full Text] [Related]
10. Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice. Faggiano P; Fattirolli F; Frisinghelli A; Piccioli L; Dasseni N; Silverii MV; Albricci L; D'Ambrosio G; Garrì R; Esposito L; Giallauria F Monaldi Arch Chest Dis; 2019 May; 89(2):. PubMed ID: 31107039 [TBL] [Abstract][Full Text] [Related]
12. Elevated risk of death and major cardiovascular events in subjects with newly diagnosed diabetes: findings from an administrative database. Monesi L; Tettamanti M; Cortesi L; Baviera M; Marzona I; Avanzini F; Monesi G; Nobili A; Riva E; Fortino I; Bortolotti A; Fontana G; Merlino L; Trevisan R; Roncaglioni MC Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):263-70. PubMed ID: 24418374 [TBL] [Abstract][Full Text] [Related]
13. Implementing intensified treatment strategies for patients with type 2 diabetes mellitus. Brunton SA; Rolla AR J Fam Pract; 2007 Nov; 56(11 Suppl Implementing):S9-16. PubMed ID: 18684359 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic strategies to improve control of hypertension. Armario P; Waeber B J Hypertens; 2013 Mar; 31 Suppl 1():S9-12. PubMed ID: 23389085 [TBL] [Abstract][Full Text] [Related]
15. Increased cardiovascular risk associated with diabetes in Dallas County. Das SR; Vaeth PA; Stanek HG; de Lemos JA; Dobbins RL; McGuire DK Am Heart J; 2006 May; 151(5):1087-93. PubMed ID: 16644340 [TBL] [Abstract][Full Text] [Related]
16. Optimal medical management of peripheral arterial disease. Rice TW; Lumsden AB Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725 [TBL] [Abstract][Full Text] [Related]
17. Highlights of the 2003 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Lawton C CANNT J; 2004; 14(1):40-3. PubMed ID: 15544171 [No Abstract] [Full Text] [Related]
18. Managing blood glucose levels in patients with diabetes and renal impairment. Chowdhury TA; O'Toole S; Yaqoob MM Br J Hosp Med (Lond); 2016 Jan; 77(1):C10-3. PubMed ID: 26903465 [No Abstract] [Full Text] [Related]
19. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction. Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577 [TBL] [Abstract][Full Text] [Related]
20. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]